Related Experiment Video
Updated: Jun 6, 2025

13:01
Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
Published on: June 3, 2022
3.6K
Deep Learning for Automated Segmentation of Basal Cell Carcinoma on Mohs Micrographic Surgery Frozen Section Slides
Vamsi Varra1, Kathryn T Shahwan1,2,3, Kirsten Johnson1
1The Ohio State University Wexner Medical Center, Columbus, Ohio.
Summary
This study developed a deep learning model to locate basal cell carcinoma (BCC) on Mohs surgery (MMS) slides, achieving good accuracy that varied by BCC subtype. Further research is needed for improved clinical performance metrics.
Area of Science:
- Dermatopathology
- Computational Pathology
- Artificial Intelligence in Medicine
Background:
- Deep learning models have shown success in classifying basal cell carcinoma (BCC) from histopathologic images.
- Segmentation models are crucial for tumor localization in Mohs surgery (MMS) frozen sections but lack clinical utility.
Purpose of the Study:
- To develop and evaluate a segmentation model for localizing BCC on MMS frozen section slides.
- To assess the model's performance across different BCC subtypes.
Main Methods:
- Utilized 348 BCC patient frozen tissue slides for whole slide imaging.
- Manually annotated BCC foci using the Grand Challenge platform.
- Employed the Ultralytics YOLOv8 model for segmentation, with data split for training, validation, and testing.
Main Results:
- Achieved an overall sensitivity of 0.71 and specificity of 0.75 for BCC tumor localization.
- Performance varied by subtype: nodular BCC (sensitivity 0.87), superficial BCC (sensitivity 0.79), micronodular BCC (sensitivity 0.74), and morpheaform/infiltrative BCC (sensitivity 0.51).
- Specificity also showed subtype variations, with micronodular BCC achieving 0.83 and nodular BCC 0.59.
Conclusions:
- A deep learning segmentation model can localize BCC on MMS frozen sections with notable sensitivity and specificity.
- Model performance is dependent on the specific BCC subtype.
- Development of more accurate and clinically relevant performance metrics for segmentation studies is essential.

